327162-41-4

Upstream product

• 123-11-5 4-methoxy-benzaldehyde 
• 209597-97-7 ethyl 2-chloro-2-methylthioacetate 
• 145628-18-8 ethyl 2-chloro-2-methylthio-acetate 
• 144-55-8 sodium hydrogencarbonate 

Downstream Products

• 378232-46-3 2-methylthio-2-(5-formyl-2-methoxyphenyl)acetic acid 
• 378231-93-7 benzyl 2-methylthio-2-(5-formyl-2-methoxyphenyl)acetate 
• 378231-96-0 2-[5-(2-ethoxycarbonyl)butyl-2-methoxyphenyl]acetic Acid 
• 378231-95-9 benzyl 2-[5-[1-(2-ethoxycarbonyl)butenyl]-2-methoxyphenyl]acetate 
• 378231-94-8 benzyl 2-methylthio-2-[5-[1-(2-ethoxycarbonyl)butenyl]-2-methoxyphenyl]acetate 
• 334015-59-7 ethyl 2-ethyl-3-[4-methoxy-3-[[N-[4-(trifluoromethyl)phenyl]carbamoyl]methyl]phenyl]propanoate 

Relevant academic research and scientific papers

Substituted phenylpropionic acid derivatives

The invention provides novel substituted phenylpropionic acid derivatives that bind to the receptor as ligands of human peroxisome proliferator-activated receptor a (PPARα) to activate and exhibit potent lipid-decreasing action, and processes for preparin

Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators

Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereoche

SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES

The invention provides novel substituted benzylthiazolidine-2,4-dione derivatives that bind to receptor to activate as ligands of human peroxisome proliferator-activated receptor (PPAR) and exhibit blood glucose-decreasing action and lipid-decreasing acti